How Assistance Works
Streamlining our patient’s specialty pharmacy experience with unmatched full-service convenience
-
1. Check Your Coverage/Benefits Verification
Our team of expert billers finds the best avenues of coverage that minimize out-of-pocket costs.
-
2. Transfer Prescription to AmeriPharma®
We process your prescription by working with your previous pharmacy or prescriber, making the transition quick and easy.
-
3. Prior Authorization
Our team of specialists obtains approval from your insurance companies within 24 to 72 hours.
-
4. Copay Assistance & Financial Aid
We secure financial aid and decrease copays, out-of-pocket expenses, and high deductibles. To date, AmeriPharma® Specialty Care has secured $55 million in financial assistance for our patients.
-
5. Nursing Care Coordination If Needed
AmeriPharma® puts your schedule and home environment first when scheduling and coordinating one of our specialized nurses for your in-home infusions.
-
6. Delivery Coordination
Medications are always delivered in strict compliance with the specific requirements for shipping. Next-day and overnight cold-chain deliveries are coordinated around your schedule.
What Is Eloctate?
Sanofi’s Eloctate is a long-acting antihemophilic factor (recombinant) used to treat hemophilia A in children and adults. It was approved by the FDA in June 2014.
- Eloctate is a long-acting recombinant factor VIII therapy used to treat hemophilia A in both children and adults.
- It works by replacing the missing factor VIII protein, which is essential for proper blood clotting.
- Eloctate is administered intravenously, and the dosage is determined by a healthcare provider based on factors like body weight and bleeding severity.
- Common side effects include joint/muscle pain, tiredness, headache, and rash, and there is a risk of developing inhibitors (antibodies) that can reduce the medication’s effectiveness.
What Is Eloctate Used For?
Eloctate is a brand-name prescription product. It contains the active ingredient, recombinant clotting factor VIII, also called the recombinant antihemophilic factor. Eloctate belongs to a medication class called antihemophilic factors.
A healthcare provider may prescribe Eloctate for children and adults with hemophilia A to:
- Control and prevent bleeding episodes
- Prevent bleeding during surgery
- Reduce the frequency of bleeding episodes
In people with hemophilia A, blood doesn’t clot properly, as they have a coagulation factor VIII deficiency. Factor VIII deficiency increases the risk of unexplained bleeding or, in severe cases, potentially fatal internal bleeding.
Eloctate shouldn’t be used to treat another similar bleeding disorder called von Willebrand disease.
Copay and Financial Assistance
AmeriPharma® Specialty Pharmacy alleviates financial burdens for patients and their families
-
Advanced software locates funding sources to match you with top-dollar foundation programs
-
One of our copay assistance specialists will assist with the application process
-
Automatic updates will be sent to you and your physician on the status of the funding
Eloctate Dosing
Eloctate Factor VIII Therapy Dosing for Control of Bleeding Episodes
Minor and moderate bleeding: 20 – 30 IU/kg IV to achieve factor VIII level of 40% – 60% of normal. Repeat every 24 – 48 hours until bleeding is resolved.
Major bleeding: 40 – 50 IU/kg IV to achieve factor VIII level of 80% – 100% of normal. Repeat Eloctate treatment every 12 – 24 hours until bleeding is resolved.
Eloctate Factor VIII Therapy Dosing for Preventing Bleeding During Surgery
Minor surgery: 25 – 40 IU/kg IV to achieve factor VIII level of 50% – 80% of normal. A repeat dose every 24 hours may be necessary for at least one day until healing is achieved.
Major surgery: 40 – 60 IU/kg IV before surgery to achieve a factor VIII level of 80% – 120% of normal. Repeat a dose of 40 – 50 IU/kg IV after 8 – 24 hours, then every 24 hours until the wound heals. Continue Eloctate treatment for at least one week.
Eloctate Factor VIII Therapy Dosing for Routine Prevention of Bleeding Episodes
- The recommended starting dose of Eloctate injections is 50 IU/kg IV every 4 days. The dosage may be adjusted depending on your response, with a dosing range of 25 – 65 IU/kg at 3 – 5 day intervals.
- For children younger than 6 years old diagnosed with hemophilia A, the recommended starting dose of Eloctate is 50 IU/kg IV twice weekly. The dosage may be adjusted depending on the response, with a dosing range of 25 – 65 IU/kg at 3 – 5 day intervals.
Eloctate Side Effects
The most common side effects in previously treated individuals can include:
- Joint or muscle pain
- Tiredness
- Headache
- Rash
The most common side effects in previously untreated individuals can include:
- Inhibitor (antibody) production
- Rash
- Blood clots at the infusion site
Insurances Accepted
We accept Medicare, multi-state Medicaid, Medi-Cal, Blue Shield, and most private insurances. Call us to find out more about your coverage.
Get Started in Minutes
Fill out your information and one of our specialists will call you ASAP.
How Much Can You Save?
Complete this form to save up to 100%!
By submitting, you agree to AmeriPharma’s Terms of Use, Privacy Policy, and Notice of Privacy Practices